3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Carcinoma, Renal Cell
3
Carcinoma, Hepatocellular
3
Melanoma
2
Endometrial Neoplasms
2
von Hippel-Lindau Disease
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Ovarian Neoplasms
1
Neoplasms
1
Hematologic Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Adenoid Cystic
1
Brain Neoplasms
1
Bone Neoplasms
1
Advanced Malignancies
1
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
1
Adenocarcinoma
1
Interventions
fludarabine
9
Cyclophosphamide
8
fludarabine phosphate
7
Specimen Handling
7
Cytarabine
7
Biopsy
7
venetoclax
6
Whole-Body Irradiation
6
Busulfan
6
Azacitidine
6
Mycophenolic Acid
5
Melphalan
5
Injections
5
decitabine and cedazuridine drug combination
4
Tacrolimus
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Cyclosporine
4
CPX-351
4
X-Rays
3
Stem Cell Transplantation
3
Peripheral Blood Stem Cell Transplantation
3
Magnetic Resonance Spectroscopy
3
treosulfan
2
ruxolitinib
2
luspatercept
2
ivosidenib
2
gilteritinib
2
Sirolimus
2
Photons
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
lenvatinib
×
30 days
×
Clear all
No trials found.